Malignancy is the second most common single cause of death observed in organ transplant
recipients. The excess cancer risk is related to intensity and duration of immunosuppressive …

Complications of Immunosuppressive Therapy in Solid Organ Transplantation - Radiologic
Clinics Skip to Main Content Radiologic Clinics Log in Register Log in Subscribe Claim Skip …

It is estimated that solid organ transplant recipients have a two-to fourfold greater overall risk
of malignancy than the general population. Some of the most common malignancies after …

Although increased rates of solid organ cancers have been reported following liver
transplantation (LT), the impact of quantitative exposure to calcineurin inhibitors (CNI) …

Life expectancies for solid organ recipients as well as graft survival rates for these patients
have improved over the years because of advanced immunosuppressive therapies; …

Evidence is sparse on the relative mortality risk posed by de novo cancers in liver and
cardiothoracic transplant recipients. A retrospective cohort study was conducted in Australia …

Abstract Background & Aims Increased rates of solid organ cancers post‐liver
transplantation have been reported, but the contribution of environmental factors and …

Currently, alcoholic cirrhosis is the second leading indication for liver transplantation in the
United States and Europe. The quality of life and survival after a liver transplantation (LT) in …

De novo malignancies constitute an emerging cause of morbidity after solid organ transplant
(SOT), significantly affecting the long-term survival of transplant recipients. Pharmacologic …

Organ transplantation is an increasingly used medical procedure for treating otherwise fatal
end-stage organ diseases, and a large number of anti-rejection drugs have been developed …